Compound information
- Natural Products
- ZC1524688
- Molecular Formula
- C19H22N2O5S
- Molecular Weight
- 390.124942804 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-phenoxyphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C19H22N2O5S/c1-2-25-19(22)20-12-14-21(15-13-20)27(23,24)18-10-8-17(9-11-18)26-16-6-4-3-5-7-16/h3-11H,2,12-15H2,1H3
- InChI Key
- XESNTONXTDDGMN-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc(Oc3ccccc3)cc2)CC1
- Source
- ZINC000044899890
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 3.368 |
LogS | -4.773 | LogD | 3.555 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.018 | Pgp substrate | 0.012 |
HIA | 0.974 | F20 % | 0.975 |
F30 % | 0.65 | Caco-2 | -4.568 |
MDCK | -4.834 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.449 | PPB | 89.345 |
VD | 0.666 | Fu | 1.441 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.087 | CYP1A2 substrate | 0.581 |
CYP2A6 substrate | 0.637 | CYP2B6 substrate | 0.658 |
CYP2C19 inhibitor | 0.904 | CYP2C19 substrate | 0.839 |
CYP2C8 substrate | 0.688 | CYP2C9 inhibitor | 0.985 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.139 |
CYP2D6 substrate | 0.732 | CYP2E1 substrate | 0.863 |
CYP3A4 inhibitor | 0.086 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.539 | CL | 4.157 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.801 | Hepatotoxicity | 0.871 |
Mutagenicity | 0.064 | Rat Oral Acute Toxicity | 0.547 |
FDAMDD | 0.589 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.791 | Eye Corrosion | 0.002 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.167 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.684 | IGC50 | 3.98 |
LC50FM | 3.023 | LC50DM | -0.573 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.222 | NR-AR-LBD | 0.411 |
NR-AhR | 0.284 | NR-Aromatase | 0.314 |
NR-ER | 0.477 | NR-ER-LBD | 0.425 |
NR-PPAR-gamma | 0.145 | SR-ARE | 0.79 |
SR-ATAD5 | 0.318 | SR-HSE | 0.112 |
SR-MMP | 0.036 | SR-p53 | 0.037 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.